HGWM
ABBV icon

Horst & Graben Wealth Management’s AbbVie ABBV Stock Holding History

Horst & Graben Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Sell
1,370
-11
-0.8% -$2.37K 0.05% 149
2026
Q1 		$273K Buy
1,381
+48
+4% +$10.6K 0.04% 165
2025
Q4 		$305K Buy
1,333
+12
+0.9% +$2.73K 0.05% 137
2025
Q3 		$306K Buy
1,321
+48
+4% +$9.78K 0.05% 138
2025
Q2 		$236K Buy
1,273
+19
+2% +$3.53K 0.04% 155
2025
Q1 		$263K Buy
1,254
+106
+9% +$20.6K 0.05% 129
2024
Q4 		$204K Buy
1,148
+5
+0.4% +$919 0.04% 151
2024
Q3 		$226K Buy
+1,143
New +$213K 0.04% 143
2023
Q4 		– Sell
-1,412
Closed -$210K – 137
2023
Q3 		$210K Buy
+1,412
New +$207K 0.05% 125
2023
Q2 		– Sell
-1,366
Closed -$218K – 131
2023
Q1 		$218K Buy
1,366
+10
+0.7% +$1.53K 0.05% 121
2022
Q4 		$219K Buy
+1,356
New +$208K 0.06% 120
2022
Q3 		– Sell
-1,336
Closed -$205K – 124
2022
Q2 		$205K Buy
1,336
+9
+0.7% +$1.38K 0.06% 124
2022
Q1 		$215K Buy
+1,327
New +$193K 0.05% 125

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Horst & Graben Wealth Management's ABBV Position: Q2 2026 in Review

Horst & Graben Wealth Management reduced its AbbVie (ABBV) stake by 0.8% in Q2 2026, selling an estimated $2.37K and leaving 1,370 shares worth $344K. The position accounts for 0.05% of the portfolio, ranked #149.

Horst & Graben Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 13 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Horst & Graben Wealth Management held 1,370 shares of AbbVie worth $344K as of Q2 2026.
  • Horst & Graben Wealth Management sold 11 AbbVie shares in Q2 2026, an estimated $2.37K.
  • AbbVie made up 0.05% of Horst & Graben Wealth Management's portfolio in Q2 2026, its #149 holding.
  • Horst & Graben Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 13 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Horst & Graben Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.